Purchases and Sales Made in Q2 2024 in Collegium Pharmaceutical, Inc (COLL)
This table provides information about the institutional ownership of Collegium Pharmaceutical, Inc (COLL) during Q2 2024. The information is specifically focused on institutions that hold shares of COLLEGIUM PHARMACEUTICAL, INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-67.7K- 34.09% |
$2.12M - $2.71M
|
131K
$4.22M
|
|
Aug 13, 2024
Q2 2024
|
Loomis Sayles & CO L P
|
SELL
|
- |
-70.6K- 25.98% |
$2.22M - $2.83M
|
201K
$6.49M
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-72.5K- 1.24% |
$2.27M - $2.9M
|
5.79M
$187M
|
|
Aug 13, 2024
Q2 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-92.4K- 85.4% |
$2.9M - $3.7M
|
15.8K
$510K
|
|
Aug 08, 2024
Q2 2024
|
South Dakota Investment Council
Sioux Falls, SD |
SELL
|
- |
-125K- 79.14% |
$3.92M - $4.99M
|
32.9K
$1.06M
|
|
Jul 31, 2024
Q2 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-143K- 91.51% |
$4.49M - $5.72M
|
13.3K
$428K
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-176K- 63.45% |
$5.52M - $7.03M
|
101K
$3.27M
|
|
Aug 14, 2024
Q2 2024
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-206K- 73.88% |
$6.45M - $8.23M
|
72.7K
$2.35M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-206K- 24.6% |
$6.46M - $8.23M
|
631K
$20.4M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-206K- 24.6% |
$6.46M - $8.23M
|
631K
$20.4M
|
|
Aug 14, 2024
Q2 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-244K- 67.63% |
$7.66M - $9.77M
|
117K
$3.77M
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-549K- 97.53% |
$17.2M - $22M
|
13.9K
$449K
|